Human Gene CD44 (ENST00000428726.8) from GENCODE V44
  Description: Homo sapiens CD44 molecule (Indian blood group) (CD44), transcript variant 1, mRNA. (from RefSeq NM_000610)
RefSeq Summary (NM_000610): The protein encoded by this gene is a cell-surface glycoprotein involved in cell-cell interactions, cell adhesion and migration. It is a receptor for hyaluronic acid (HA) and can also interact with other ligands, such as osteopontin, collagens, and matrix metalloproteinases (MMPs). This protein participates in a wide variety of cellular functions including lymphocyte activation, recirculation and homing, hematopoiesis, and tumor metastasis. Transcripts for this gene undergo complex alternative splicing that results in many functionally distinct isoforms, however, the full length nature of some of these variants has not been determined. Alternative splicing is the basis for the structural and functional diversity of this protein, and may be related to tumor metastasis. [provided by RefSeq, Jul 2008].
Gencode Transcript: ENST00000428726.8
Gencode Gene: ENSG00000026508.21
Transcript (Including UTRs)
   Position: hg38 chr11:35,139,171-35,232,402 Size: 93,232 Total Exon Count: 18 Strand: +
Coding Region
   Position: hg38 chr11:35,139,304-35,229,333 Size: 90,030 Coding Exon Count: 18 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
RNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther SpeciesGO Annotations
mRNA DescriptionsPathwaysOther NamesMethods
Data last updated at UCSC: 2023-08-18 00:09:47

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr11:35,139,171-35,232,402)mRNA (may differ from genome)Protein (742 aa)
Gene SorterGenome BrowserOther Species FASTAGene interactionsTable SchemaAlphaFold
BioGPSEnsemblEntrez GeneExonPrimerGencodeGeneCards
HGNCHPRDLynxMalacardsMGIneXtProt
OMIMPubMedReactomeUniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: CD44_HUMAN
DESCRIPTION: RecName: Full=CD44 antigen; AltName: Full=CDw44; AltName: Full=Epican; AltName: Full=Extracellular matrix receptor III; Short=ECMR-III; AltName: Full=GP90 lymphocyte homing/adhesion receptor; AltName: Full=HUTCH-I; AltName: Full=Heparan sulfate proteoglycan; AltName: Full=Hermes antigen; AltName: Full=Hyaluronate receptor; AltName: Full=Phagocytic glycoprotein 1; Short=PGP-1; AltName: Full=Phagocytic glycoprotein I; Short=PGP-I; AltName: CD_antigen=CD44; Flags: Precursor;
FUNCTION: Receptor for hyaluronic acid (HA). Mediates cell-cell and cell-matrix interactions through its affinity for HA, and possibly also through its affinity for other ligands such as osteopontin, collagens, and matrix metalloproteinases (MMPs). Adhesion with HA plays an important role in cell migration, tumor growth and progression. Also involved in lymphocyte activation, recirculation and homing, and in hematopoiesis. Altered expression or dysfunction causes numerous pathogenic phenotypes. Great protein heterogeneity due to numerous alternative splicing and post-translational modification events.
SUBUNIT: Interacts with PKN2 (By similarity). Interacts with HA, as well as other glycosaminoglycans, collagen, laminin, and fibronectin via its N-terminal segment. Interacts with ANK, the ERM proteins (VIL2, RDX and MSN), and NF2 via its C-terminal segment.
INTERACTION: P18011:ipaB (xeno); NbExp=4; IntAct=EBI-490245, EBI-490239; Q9UPY5:SLC7A11; NbExp=4; IntAct=EBI-490245, EBI-3843348;
SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein. Note=Colocalizes with actin in membrane protrusions at wounding edges (By similarity).
TISSUE SPECIFICITY: Isoform 10 (epithelial isoform) is expressed by cells of epithelium and highly expressed by carcinomas. Expression is repressed in neuroblastoma cells.
DOMAIN: The lectin-like LINK domain is responsible for hyaluronan binding (By similarity).
PTM: Proteolytically cleaved in the extracellular matrix by specific proteinases (possibly MMPs) in several cell lines and tumors.
PTM: N- and O-glycosylated. O-glycosylation contains more-or-less- sulfated chondroitin sulfate glycans, whose number may affect the accessibility of specific proteinases to their cleavage site(s). It is uncertain if O-glycosylation occurs on Thr-637 or Thr-638.
PTM: Phosphorylated; activation of PKC results in the dephosphorylation of Ser-706 (constitutive phosphorylation site), and the phosphorylation of Ser-672.
POLYMORPHISM: CD44 is responsible for the Indian blood group system. The molecular basis of the In(A)=In1/In(B)=In2 blood group antigens is a single variation in position 46; In(B), the most frequent allele, has Arg-46.
SIMILARITY: Contains 1 Link domain.
WEB RESOURCE: Name=dbRBC/BGMUT; Note=Blood group antigen gene mutation database; URL="http://www.ncbi.nlm.nih.gov/gv/mhc/xslcgi.cgi?cmd=bgmut/systems_info&system=indian";
WEB RESOURCE: Name=Wikipedia; Note=CD44 entry; URL="http://en.wikipedia.org/wiki/CD44";

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: CD44
Diseases sorted by gene-association score: superficial keratitis (18), lichen sclerosus (17), intraductal papilloma (15), hodgkin's lymphoma, lymphocytic-histiocytic predominance (13), acute monoblastic leukemia (13), warthin tumor (12), larynx cancer (12), skin atrophy (11), congenital dyserythropoietic anemia (11), prostate leiomyosarcoma (10), tarsal-carpal coalition syndrome (8), stomach cancer (8), colorectal cancer (8), deafness, autosomal recessive 51 (7), inflammatory bowel disease 16 (7), ovarian clear cell carcinoma (7), cd3zeta deficiency (7), gastric adenosquamous carcinoma (7), breast adenoma (7), fibrochondrogenesis (7), squamous cell carcinoma, head and neck (7), rheumatoid vasculitis (7), mast cell disease (6), gastrointestinal neuroendocrine tumor (6), breast ductal carcinoma (6), omodysplasia (6), tongue cancer (6), schwartz-jampel syndrome, type 1 (6), hydrocele (6), mucinoses (5), bladder cancer, somatic (5), lung cancer (5), small intestinal adenocarcinoma (5), breast giant fibroadenoma (5), colon carcinoma in situ (5), spinal cord astrocytoma (4), brain germinoma (4), hepatocellular carcinoma (4), cerebral primitive neuroectodermal tumor (4), transitional cell carcinoma (4), gastric adenocarcinoma (4), endometrial cancer (4), ovarian cancer, somatic (4), breast cancer (4), multiple myeloma (3), glomangioma (3), streptococcal meningitis (3), chandler syndrome (3), juvenile pilocytic astrocytoma (3), neuroblastoma (3), oral squamous cell carcinoma (3), renal cell carcinoma (3), pancreatic cancer (3), prostate cancer (3), brain cancer (3), cervical cancer, somatic (2), esophageal cancer (2), lymphoma, non-hodgkin (2), eye disease (2), gastrointestinal system cancer (1), pancreas adenocarcinoma (1), cell type cancer (1), reproductive organ cancer (1)

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 102.51 RPKM in Skin - Not Sun Exposed (Suprapubic)
Total median expression: 1206.25 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -35.70133-0.268 Picture PostScript Text
3' UTR -829.503069-0.270 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR016186 - C-type_lectin-like
IPR016187 - C-type_lectin_fold
IPR001231 - CD44_antigen
IPR000538 - Link

Pfam Domains:
PF00193 - Extracellular link domain

Protein Data Bank (PDB) 3-D Structure
MuPIT help
1POZ - NMR MuPIT 1UUH - X-ray MuPIT 2I83 - NMR MuPIT


ModBase Predicted Comparative 3D Structure on P16070
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
Genome BrowserGenome BrowserNo orthologNo orthologNo orthologNo ortholog
Gene Details     
Gene Sorter     
MGIRGD    
Protein SequenceProtein Sequence    
AlignmentAlignment    

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0005515 protein binding
GO:0005518 collagen binding
GO:0005540 hyaluronic acid binding
GO:0004896 cytokine receptor activity

Biological Process:
GO:0007155 cell adhesion
GO:0007160 cell-matrix adhesion
GO:0022617 extracellular matrix disassembly
GO:0030198 extracellular matrix organization
GO:0030214 hyaluronan catabolic process
GO:0033138 positive regulation of peptidyl-serine phosphorylation
GO:0034116 positive regulation of heterotypic cell-cell adhesion
GO:0043066 negative regulation of apoptotic process
GO:0043154 negative regulation of cysteine-type endopeptidase activity involved in apoptotic process
GO:0043312 neutrophil degranulation
GO:0043518 negative regulation of DNA damage response, signal transduction by p53 class mediator
GO:0044319 wound healing, spreading of cells
GO:0044344 cellular response to fibroblast growth factor stimulus
GO:0050731 positive regulation of peptidyl-tyrosine phosphorylation
GO:0050900 leukocyte migration
GO:0051216 cartilage development
GO:0060333 interferon-gamma-mediated signaling pathway
GO:0070374 positive regulation of ERK1 and ERK2 cascade
GO:0070487 monocyte aggregation
GO:0098609 cell-cell adhesion
GO:1900625 positive regulation of monocyte aggregation
GO:1902166 negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator
GO:2000392 regulation of lamellipodium morphogenesis

Cellular Component:
GO:0005794 Golgi apparatus
GO:0005829 cytosol
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0005902 microvillus
GO:0005925 focal adhesion
GO:0009986 cell surface
GO:0016020 membrane
GO:0016021 integral component of membrane
GO:0016324 apical plasma membrane
GO:0030667 secretory granule membrane
GO:0031258 lamellipodium membrane
GO:0035692 macrophage migration inhibitory factor receptor complex
GO:0042995 cell projection
GO:0070062 extracellular exosome


-  Descriptions from all associated GenBank mRNAs
  LF211833 - JP 2014500723-A/19336: Polycomb-Associated Non-Coding RNAs.
MA447410 - JP 2018138019-A/19336: Polycomb-Associated Non-Coding RNAs.
LQ969649 - Sequence 133 from Patent WO2014198843.
LQ969633 - Sequence 117 from Patent WO2014198843.
LQ969635 - Sequence 119 from Patent WO2014198843.
LQ969636 - Sequence 120 from Patent WO2014198843.
LQ969637 - Sequence 121 from Patent WO2014198843.
LQ969638 - Sequence 122 from Patent WO2014198843.
LQ969639 - Sequence 123 from Patent WO2014198843.
LQ969641 - Sequence 125 from Patent WO2014198843.
LQ969642 - Sequence 126 from Patent WO2014198843.
LQ969644 - Sequence 128 from Patent WO2014198843.
LQ969646 - Sequence 130 from Patent WO2014198843.
LQ969647 - Sequence 131 from Patent WO2014198843.
LQ969648 - Sequence 132 from Patent WO2014198843.
AL832642 - Homo sapiens mRNA; cDNA DKFZp451K1918 (from clone DKFZp451K1918); complete cds.
LF205796 - JP 2014500723-A/13299: Polycomb-Associated Non-Coding RNAs.
MA441373 - JP 2018138019-A/13299: Polycomb-Associated Non-Coding RNAs.
AK297776 - Homo sapiens cDNA FLJ52702 complete cds, highly similar to Homo sapiens CD44 antigen (homing function and Indian blood group system) (CD44), transcript variant 4, mRNA.
D28447 - Homo sapiens mRNA for CD44 antigen, 5'UTR region.
X66733 - H.sapiens mRNA for epican.
X55150 - Human mRNA for CD44E (epithelial form).
AJ251595 - Homo sapiens mRNA for transmembrane glycoprotein (CD44 gene).
BC004372 - Homo sapiens CD44 molecule (Indian blood group), mRNA (cDNA clone MGC:10468 IMAGE:3638681), complete cds.
BC052287 - Homo sapiens CD44 molecule (Indian blood group), mRNA (cDNA clone IMAGE:5428516), complete cds.
AY101193 - Homo sapiens CD44 antigen (CD44) mRNA, complete cds.
BC067348 - Homo sapiens CD44 molecule (Indian blood group), mRNA (cDNA clone IMAGE:4842331), complete cds.
AY101192 - Homo sapiens CD44 antigen (CD44) mRNA, complete cds.
X56794 - H.sapiens CD44R mRNA.
M24915 - Human CDw44 antigen, complete cds.
JD126141 - Sequence 107165 from Patent EP1572962.
U40373 - Human cell surface glycoprotein CD44 mRNA, complete cds.
S66400 - CD44=CD44SP {alternatively spliced} [human, breast carcinoma cell line MCF-7, mRNA Partial, 1586 nt].
JD149545 - Sequence 130569 from Patent EP1572962.
M59040 - Human cell adhesion molecule (CD44) mRNA, complete cds.
AF098641 - Homo sapiens CD44 isoform RC (CD44) mRNA, complete cds.
EF581837 - Homo sapiens CD44 variant mRNA, complete cds, alternatively spliced.
AB384769 - Synthetic construct DNA, clone: pF1KB3247, Homo sapiens CD44 gene for CD44 antigen precursor, complete cds, without stop codon, in Flexi system.
CU678692 - Synthetic construct Homo sapiens gateway clone IMAGE:100017774 5' read CD44 mRNA.
FJ216964 - Homo sapiens CD44 mRNA, complete cds, alternatively spliced.
AK290424 - Homo sapiens cDNA FLJ76654 complete cds, highly similar to Homo sapiens CD44 antigen (homing function and Indian blood group system) (CD44), transcript variant 4, mRNA.
M25078 - Human Hermes antigen gp90 homing receptor mRNA, 3' end.
KJ896569 - Synthetic construct Homo sapiens clone ccsbBroadEn_05963 CD44 gene, encodes complete protein.
KR709962 - Synthetic construct Homo sapiens clone CCSBHm_00008538 CD44 (CD44) mRNA, encodes complete protein.
KR709963 - Synthetic construct Homo sapiens clone CCSBHm_00008540 CD44 (CD44) mRNA, encodes complete protein.
LF348328 - JP 2014500723-A/155831: Polycomb-Associated Non-Coding RNAs.
MA583905 - JP 2018138019-A/155831: Polycomb-Associated Non-Coding RNAs.
LQ969650 - Sequence 134 from Patent WO2014198843.
LQ969643 - Sequence 127 from Patent WO2014198843.
LQ969645 - Sequence 129 from Patent WO2014198843.
LQ969634 - Sequence 118 from Patent WO2014198843.
LQ969640 - Sequence 124 from Patent WO2014198843.
AK129808 - Homo sapiens cDNA FLJ26297 fis, clone DMC07218, highly similar to Homo sapiens CD44 antigen (homing function and Indian blood group system) (CD44).
JC743452 - Sequence 7 from Patent EP2725103.
LQ969651 - Sequence 135 from Patent WO2014198843.
LF348325 - JP 2014500723-A/155828: Polycomb-Associated Non-Coding RNAs.
MA583902 - JP 2018138019-A/155828: Polycomb-Associated Non-Coding RNAs.
S82326 - CD44=cell-cell and cell-matrix adhesion interaction glycoprotein isoform {alternatively spliced, exon 4-exon 13 junction region} [human, papillary thyroid carcinoma and contralateral thyroid tissue, thyroid carcinoma patient, mRNA Mutant, 530 nt].
LQ969652 - Sequence 136 from Patent WO2014198843.
LQ969653 - Sequence 137 from Patent WO2014198843.
AK304467 - Homo sapiens cDNA FLJ60041 complete cds, highly similar to CD44 antigen precursor.
AK307707 - Homo sapiens cDNA, FLJ97655.
LF348324 - JP 2014500723-A/155827: Polycomb-Associated Non-Coding RNAs.
MA583901 - JP 2018138019-A/155827: Polycomb-Associated Non-Coding RNAs.
X55938 - Human mRNA for CD44E core protein.
M83324 - Human cell surface glycoprotein CD44 mRNA, (variant B) exon 1.
M83325 - Human cell surface glycoprotein CD44 mRNA, (variant C) exons 1 and 2.
M83326 - Human cell surface glycoprotein CD44 mRNA, (variant D) exon 1, 2, and 3.
M83327 - Human cell surface glycoprotein CD44 mRNA, (variant E) exons 1, 2, 3, and 4.
M83328 - Human cell surface glycoprotein CD44 mRNA, (variant F) exons 1, 2, 3, and 5.
AK123567 - Homo sapiens cDNA FLJ41573 fis, clone CTONG2009768.
LQ969654 - Sequence 138 from Patent WO2014198843.
LQ969655 - Sequence 139 from Patent WO2014198843.
X62739 - H.sapiens mRNA for variant CD44.
LQ969656 - Sequence 140 from Patent WO2014198843.
LQ969657 - Sequence 141 from Patent WO2014198843.
LQ969658 - Sequence 142 from Patent WO2014198843.
LQ969659 - Sequence 143 from Patent WO2014198843.
LQ969660 - Sequence 144 from Patent WO2014198843.
LQ969661 - Sequence 145 from Patent WO2014198843.
LQ969662 - Sequence 146 from Patent WO2014198843.
LQ969663 - Sequence 147 from Patent WO2014198843.
LF348321 - JP 2014500723-A/155824: Polycomb-Associated Non-Coding RNAs.
MA583898 - JP 2018138019-A/155824: Polycomb-Associated Non-Coding RNAs.
LQ969664 - Sequence 148 from Patent WO2014198843.
LQ969665 - Sequence 149 from Patent WO2014198843.
LQ969666 - Sequence 150 from Patent WO2014198843.
LF348319 - JP 2014500723-A/155822: Polycomb-Associated Non-Coding RNAs.
MA583896 - JP 2018138019-A/155822: Polycomb-Associated Non-Coding RNAs.
LF348318 - JP 2014500723-A/155821: Polycomb-Associated Non-Coding RNAs.
MA583895 - JP 2018138019-A/155821: Polycomb-Associated Non-Coding RNAs.
JD294688 - Sequence 275712 from Patent EP1572962.
LF348317 - JP 2014500723-A/155820: Polycomb-Associated Non-Coding RNAs.
MA583894 - JP 2018138019-A/155820: Polycomb-Associated Non-Coding RNAs.
JD254953 - Sequence 235977 from Patent EP1572962.
LF348316 - JP 2014500723-A/155819: Polycomb-Associated Non-Coding RNAs.
MA583893 - JP 2018138019-A/155819: Polycomb-Associated Non-Coding RNAs.
JD516638 - Sequence 497662 from Patent EP1572962.
FW573328 - JP 2010529847-A/49: Oligonucleotides for modulation of target RNA activity.
JD039896 - Sequence 20920 from Patent EP1572962.
JD417836 - Sequence 398860 from Patent EP1572962.
JD449579 - Sequence 430603 from Patent EP1572962.
LF348315 - JP 2014500723-A/155818: Polycomb-Associated Non-Coding RNAs.
MA583892 - JP 2018138019-A/155818: Polycomb-Associated Non-Coding RNAs.
LF348314 - JP 2014500723-A/155817: Polycomb-Associated Non-Coding RNAs.
MA583891 - JP 2018138019-A/155817: Polycomb-Associated Non-Coding RNAs.
AK127622 - Homo sapiens cDNA FLJ45720 fis, clone HCASM2000363.
LF348313 - JP 2014500723-A/155816: Polycomb-Associated Non-Coding RNAs.
MA583890 - JP 2018138019-A/155816: Polycomb-Associated Non-Coding RNAs.
LF348312 - JP 2014500723-A/155815: Polycomb-Associated Non-Coding RNAs.
MA583889 - JP 2018138019-A/155815: Polycomb-Associated Non-Coding RNAs.
AB073901 - Homo sapiens primary neuroblastoma cDNA, clone:Nbla03779, full insert sequence.
FW573327 - JP 2010529847-A/48: Oligonucleotides for modulation of target RNA activity.
LF348311 - JP 2014500723-A/155814: Polycomb-Associated Non-Coding RNAs.
MA583888 - JP 2018138019-A/155814: Polycomb-Associated Non-Coding RNAs.
LF348310 - JP 2014500723-A/155813: Polycomb-Associated Non-Coding RNAs.
MA583887 - JP 2018138019-A/155813: Polycomb-Associated Non-Coding RNAs.
FW573329 - JP 2010529847-A/50: Oligonucleotides for modulation of target RNA activity.
FW573326 - JP 2010529847-A/47: Oligonucleotides for modulation of target RNA activity.
LF348309 - JP 2014500723-A/155812: Polycomb-Associated Non-Coding RNAs.
MA583886 - JP 2018138019-A/155812: Polycomb-Associated Non-Coding RNAs.

-  Biochemical and Signaling Pathways
  KEGG - Kyoto Encyclopedia of Genes and Genomes
hsa04512 - ECM-receptor interaction
hsa04640 - Hematopoietic cell lineage
hsa05131 - Shigellosis

BioCarta from NCI Cancer Genome Anatomy Project
h_neutrophilPathway - Neutrophil and Its Surface Molecules
h_lymphocytePathway - Adhesion Molecules on Lymphocyte
h_monocytePathway - Monocyte and its Surface Molecules

Reactome (by CSHL, EBI, and GO)

Protein P16070 (Reactome details) participates in the following event(s):

R-HSA-1454791 MMP2, MMP7, MMP9 bind CD44
R-HSA-2752115 SPP1 (osteopontin) binds CD44
R-HSA-2160915 Receptor-mediated uptake of HA
R-HSA-2870221 E-selectin binds E-selectin ligand
R-HSA-6798743 Exocytosis of secretory granule membrane proteins
R-HSA-2160884 HA:HAR:HYAL2 binds to SLC9A1:p-CHP:Ca2+
R-HSA-1474228 Degradation of the extracellular matrix
R-HSA-216083 Integrin cell surface interactions
R-HSA-877300 Interferon gamma signaling
R-HSA-2160916 Hyaluronan uptake and degradation
R-HSA-202733 Cell surface interactions at the vascular wall
R-HSA-6798695 Neutrophil degranulation
R-HSA-1474244 Extracellular matrix organization
R-HSA-913531 Interferon Signaling
R-HSA-2142845 Hyaluronan metabolism
R-HSA-109582 Hemostasis
R-HSA-168249 Innate Immune System
R-HSA-1280215 Cytokine Signaling in Immune system
R-HSA-1630316 Glycosaminoglycan metabolism
R-HSA-168256 Immune System
R-HSA-71387 Metabolism of carbohydrates
R-HSA-1430728 Metabolism

-  Other Names for This Gene
  Alternate Gene Symbols: A5YRN9, B6EAT9, CD44_HUMAN, D3DR12, D3DR13, ENST00000428726.1, ENST00000428726.2, ENST00000428726.3, ENST00000428726.4, ENST00000428726.5, ENST00000428726.6, ENST00000428726.7, LHR, MDU2, MDU3, MIC4, NM_000610, O95370, P16070, P22511, Q04858, Q13419, Q13957, Q13958, Q13959, Q13960, Q13961, Q13967, Q13968, Q13980, Q15861, Q16064, Q16065, Q16066, Q16208, Q16522, Q86T72, Q86Z27, Q8N694, Q92493, Q96J24, Q9H5A5, Q9UC28, Q9UC29, Q9UC30, Q9UCB0, Q9UJ36, uc001mvu.1, uc001mvu.2, uc001mvu.3, uc001mvu.4, uc001mvu.5, uc001mvu.6
UCSC ID: ENST00000428726.8
RefSeq Accession: NM_000610
Protein: P16070 (aka CD44_HUMAN)
CCDS: CCDS7897.1

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.